Zotefoams PLC Full Year Trading Update (1870N)
19 Enero 2023 - 1:00AM
UK Regulatory
TIDMZTF
RNS Number : 1870N
Zotefoams PLC
19 January 2023
Zotefoams plc
("Zotefoams" or "Group")
Full year trading update
Strong performance and record profits
19 January 2023 - Zotefoams, a world leader in cellular
materials technology, today provides a trading update for the
Group's financial year ended 31 December 2022 (unaudited).
The strong trading performance reported in the Group's update of
15 December 2022 continued through to the end of the year and, as a
result, the Group expects to report full year revenue growth of
26%, to GBP127.4m (2021: GBP100.8m), which is ahead of current
market expectations.
Full year trends for the specific Group's business units were as
follows:
-- 29% growth in High Performance Product (HPP) sales to GBP54.5m
(2021: GBP42.3m):
* Footwear sales grew by 25%, with continued momentum
from new products and projects, representing
approximately 33% of Group revenue
* ZOTEK(R) fluoropolymer foam revenue increased by 48%,
principally benefitting from the continued recovery
of the aviation market
* T-FIT(R) technical insulation sales grew 48%,
overcoming continued COVID-related challenges in our
manufacturing facility in China
-- 25% growth in AZOTE(R) polyolefin sales to GBP70.1m (2021:
GBP56.2m):
* Good performance from all regions with pricing
actions recovering input cost inflation
* Volume in line with the previous year, with increases
experienced in most major geographical markets
offsetting a 5% decline in continental Europe,
primarily due to lower demand from the automotive
segment
-- 23% growth in MuCell Extrusion (MEL) sales to GBP2.8m (2021:
GBP2.3m), with increasing interest in the Group's technology
for polymer reduction. Development of the mono-material
ReZorce(R) packaging is progressing well and is currently
a significant focus of the team.
Profit before tax for the year is now expected to be not less
than GBP12.0m (2021: GBP7.0m), which is ahead of current market
expectations and represents a year-on-year increase of over 70%.
This record profit figure is net of the segment loss in the MEL
Business Unit increasing to GBP1.9m (2021: GBP0.7m), which reflects
the continued investment in the development of ReZorce packaging
technology.
The Group demonstrated strong cash generation, with the year-end
leverage multiple (net debt to EBITDA) expected to reduce to
approximately 1.16x (2021: 2.06x).
Notice of results
The Company expects to publish its preliminary results for the
year ended 31 December 2022 on Tuesday 21 March 2023.
Commenting on the update David Stirling, Group CEO of Zotefoams,
said:
"We are delighted to close the year with very strong sales
growth, delivering record profits and excellent cash generation.
2022 was characterised by uncertainty and our team has responded
well in dealing with these challenges. The Group has delivered
growth across all business units.
"We have also continued to invest in the development of ReZorce
mono-material packaging which represents a significant commitment
to new technology in the sustainability of consumer goods, in line
with our own ESG and efficiency initiatives which remain a core
focus.
"Whilst the shorter-term macroeconomic climate remains
uncertain, we continue to monitor the evolving landscape closely
and believe Zotefoams has a strong portfolio of opportunities, a
clear strategy and is well positioned to deliver further
growth."
Enquiries:
Zotefoams plc +44 (0) 208 664 1600
David Stirling, Group CEO
Gary McGrath, Group CFO
IFC Advisory (Financial PR
& IR) +44 (0) 203 934 6630
Graham Herring
Tim Metcalfe
Zach Cohen
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology delivering optimal material solutions for the
benefit of society. Utilising a variety of unique manufacturing
processes, including environmentally friendly nitrogen expansion
for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses
its own cellular materials to manufacture T-FIT(R) advanced
insulation for demanding industrial markets. Zotefoams also owns
and licenses patented microcellular foam technology to reduce
plastic use in extrusion applications and for ReZorce(R)
mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky, USA and Brzeg, Poland (foam
manufacture), Oklahoma, USA (foam products manufacture and
conversion), Massachusetts, USA, Stilling, Denmark (microcellular
foam technology) and Jiangsu Province, China (T-FIT).
www.zotefoams.com
AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered
trademarks of Zotefoams plc.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTKZGMMNRKGFZM
(END) Dow Jones Newswires
January 19, 2023 02:00 ET (07:00 GMT)
Zotefoams (LSE:ZTF)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Zotefoams (LSE:ZTF)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024